Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2016-02-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.5b01956PMID 26881291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts

  2013cited by this paper
• Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

  2013cited by this paper
• Synthesis and biological characterization of protease-activated prodrugs of doxazolidine.

  2012cited by this paper
• Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.

  2009cited by this paper
• Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations

  2008cited by this paper
• Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrug.

  2008cited by this paper
• Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism.

  2007cited by this paper
• Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases.

  2006cited by this paper
• Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA.

  2005cited by this paper
• Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.

  2005cited by this paper
• Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate

  2004cited by this paper
• Apoptosis induced by topoisomerase inhibitors.

  2003cited by this paper
• Sequence specificity of adriamycin-DNA adducts in human tumor cells.

  2003cited by this paper
• Catalytic topoisomerase II inhibitors in cancer therapy.

  2003cited by this paper
• Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.

  2003cited by this paper
• Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling.

  2001cited by this paper
• A Silver Staining Method for Single-cell Gel Assay

  2001cited by this paper
• Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells.

  2000cited by this paper
• Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells.

  1999cited by this paper
• Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.

  1998cited by this paper
• Characterization of covalent adriamycin-DNA adducts.

  1998cited by this paper
• Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.

  1997cited by this paper
• Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.

  1997cited by this paper
• Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.

  1996cited by this paper
• Detection of DNA‐crosslinking agents with the alkaline comet assay

  1996cited by this paper
• Cellular resistance to anthracyclines.

  1996cited by this paper
• A possible mechanism for adriamycin induced cardiotoxicity.

  1994cited by this paper
• Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution.

  1993cited by this paper
• Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies.

  1992cited by this paper
• The anthracyclines: will we ever find a better doxorubicin?

  1992cited by this paper
• Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

  1990cited by this paper
• Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.

  1990cited by this paper
• Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity.

  1990cited by this paper
• Multidrug resistance in cancer.

  1989cited by this paper
• Compounds with bridgehead nitrogen. 50 —1H NMR spectra and structures of the products derived from the reaction between trans‐3‐aminotetralin‐2‐ol and formaldehyde

  1986cited by this paper
• Compounds with bridgehead nitrogen. Part 47. The reaction between trans-1-aminobenzocycloalkan-2-ols and formaldehyde

  1984cited by this paper
• Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

  1983cited by this paper
• Analysis of combined drug effects: a new look at a very old problem

  1983cited by this paper
• The anthracycline antineoplastic drugs.

  1981cited by this paper
• Ring-chain tautomerism in 1,3-diaza and 1,3-oxaza heterocycles

  1980cited by this paper
• The reaction of trans-2-aminocyclohexanol with formaldehyde

  1967cited by this paper

• ROS‐Activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm

  2024cites this paper
• The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production

  2024cites this paper
• Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery.

  2023cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Long‐term prevention of bladder cancer progression by alpha1‐oleate alone or in combination with chemotherapy

  2023cites this paper
• The Mechanism of Dynamic Interaction between Doxorubicin and Calf Thymus DNA at the Single-Molecule Level Based on Confocal Raman Spectroscopy

  2022cites this paper
• Acid-triggered degradable polyprodrug with drug as unique repeating unit for long-acting drug delivery with minimal leakage.

  2021cites this paper
• Formaldehyde-doxorubicin dual polymeric drug delivery system for higher efficacy and limited cardiotoxicity of anthracyclines

  2020cites this paper
• Synthesis of Acid-Labile Poly(Doxazolidine) as Polyprodrug with Ultra-High Drug Content for Self-Delivery of High-Performance Chemotherapeutics.

  2020cites this paper
• Synthetic routes to nanoconjugates of anthracyclines.

  2020cites this paper
• Human serum albumin-based dual-agent delivery systems for combination therapy: acting against cancer cells and inhibiting neovascularization in the tumor microenvironment.

  2020cites this paper
• Molecular avenues in targeted doxorubicin cancer therapy.

  2020cites this paper
• Theranostic Nanocarriers Combining High Drug Loading and Magnetic Particle Imaging.

  2019cites this paper
• Catalytic oxidation of benzyl alcohols by new Cu(II) complexes of 1,3-oxazolidine based ligand obtained from a solvent free reaction

  2018cites this paper
• Expedient stereospecific Co-catalyzed tandem C-N and C-O bond formation of N-methylanilines with styrene oxides.

  2018cites this paper
• The Role of Formaldehyde in Cell Proliferation and Death

  2017cites this paper